These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 32779796)
21. Primary pulmonary lymphoma. Graham BB; Mathisen DJ; Mark EJ; Takvorian RW Ann Thorac Surg; 2005 Oct; 80(4):1248-53. PubMed ID: 16181848 [TBL] [Abstract][Full Text] [Related]
22. Clinical Analysis of 50 Cases of Primary Pulmonary Lymphoma: A Retrospective Study and Literature Review. Hu M; Gu W; Chen S; Mei J; Wang W Technol Cancer Res Treat; 2022; 21():15330338221075529. PubMed ID: 35253550 [No Abstract] [Full Text] [Related]
23. Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study. Oh SY; Kim WS; Kim JS; Kim SJ; Kwon HC; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Lee GW; Choi CW; Park J; Suh C; Kim HJ Ann Hematol; 2010 Jun; 89(6):563-8. PubMed ID: 20024551 [TBL] [Abstract][Full Text] [Related]
24. Outcomes of primary thyroid non-Hodgkin's lymphoma: a series of nine consecutive cases. Colović M; Matić S; Kryeziu E; Tomin D; Colović N; Atkinson HD Med Oncol; 2007; 24(2):203-8. PubMed ID: 17848745 [TBL] [Abstract][Full Text] [Related]
25. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol]. Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405 [TBL] [Abstract][Full Text] [Related]
27. Treatment Outcome in Patients with Primary or Secondary Transformed Indolent B-Cell Lymphomas. Demirdas S; Hense J; Dührsen U; Hüttmann A Oncol Res Treat; 2019; 42(11):580-588. PubMed ID: 31536987 [TBL] [Abstract][Full Text] [Related]
28. Treatment results of tonsillar lymphoma: a 10-year experience. Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316 [TBL] [Abstract][Full Text] [Related]
29. Combined modality treatment for primary gastrointestinal non-Hodgkin's lymphoma: the Milan Cancer Institute experience. Tondini C; Giardini R; Bozzetti F; Valagussa P; Santoro A; Bertulli R; Balzarotti M; Rocca A; Lombardi F; Ferreri AJ Ann Oncol; 1993 Dec; 4(10):831-7. PubMed ID: 8117602 [TBL] [Abstract][Full Text] [Related]
30. Prognostic factors of Chinese patients with primary pulmonary non-Hodgkin's lymphoma: the single-institute experience in Taiwan. Hu YH; Hsiao LT; Yang CF; Chiou TJ; Liu JH; Gau JP; Yen CC; Chou TY; Hsu WH; Chen PM; Tzeng CH Ann Hematol; 2009 Sep; 88(9):839-46. PubMed ID: 19139892 [TBL] [Abstract][Full Text] [Related]
32. [Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma]. Zhang HY; Lin TY; Jiang WQ; Zhang L; Huang HQ; Xia ZJ; Sun XF; He YJ; Guan ZZ Ai Zheng; 2004 Dec; 23(12):1681-6. PubMed ID: 15601560 [TBL] [Abstract][Full Text] [Related]
33. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity]. Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624 [TBL] [Abstract][Full Text] [Related]
34. Primary pulmonary lymphoma: diagnosis and follow-up of 6 cases and review of an uncommon entity. Varona JF; Guerra JM; Grande C; Villena V; González-Lois C; Martínez MA Tumori; 2005; 91(1):24-9. PubMed ID: 15850001 [TBL] [Abstract][Full Text] [Related]
35. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases]. He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382 [TBL] [Abstract][Full Text] [Related]
37. Debate on the conservative and aggressive treatment options for the optimal management of indolent non-Hodgkin's lymphoma. Imrie KR; Linch DC; Czuczman MS Anticancer Drugs; 2002 Nov; 13 Suppl 2():S19-24. PubMed ID: 12710587 [TBL] [Abstract][Full Text] [Related]
38. [Ki-67 proliferative index in non-Hodgkin's lymphoma and its clinical significance]. Li J; Hu R; Liao AJ; Shi HY; Yan W; Liu ZG Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):935-9. PubMed ID: 21867618 [TBL] [Abstract][Full Text] [Related]
39. Early-stage primary bone lymphoma: a retrospective, multicenter Rare Cancer Network (RCN) Study. Cai L; Stauder MC; Zhang YJ; Poortmans P; Li YX; Constantinou N; Thariat J; Kadish SP; Nguyen TD; Kirova YM; Ghadjar P; Weber DC; Bertran VT; Ozsahin M; Mirimanoff RO Int J Radiat Oncol Biol Phys; 2012 May; 83(1):284-91. PubMed ID: 22079728 [TBL] [Abstract][Full Text] [Related]
40. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil]. Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]